• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

SoftOx Solutions

Less than 1K followers

SOFTX

Euronext Growth Oslo

Biotechnology & Pharmaceuticals

Health Care

Overview
Investor consensus

SoftOx Solutions is a Norwegian medical technology company. The company has developed a proprietary solution based on acetic acid for the treatment of chronic wounds in patients. The solution is used to eliminate infections associated with biofilms, which consist of different clusters of bacteria. Part of the drug development is done in collaboration with other research institutes. SoftOx Solutions was founded in 2012 and is headquartered in Oslo, Norway.

Read more
Market cap
-
Turnover
-
Revenue
15.58M
EBIT %
-72.97 %
P/E
-
Dividend yield-%
-
Financial calendar
23.9
2026

Interim report Q2'26

25.11
2026

Interim report Q3'26

24.3
2027

Annual report '26

All
Press releases
ShowingAll content types

Regulatory press release07.07.2026, 15.24

SoftOx Solution AS: Mandatory notification of trade by primary insider related to the Private Placement and Debt Conversion.

SoftOx Solutions
Regulatory press release06.07.2026, 20.05

SoftOx Solutions AS: Private Placement Resolved

SoftOx Solutions
Regulatory press release26.06.2026, 09.00

SoftOx Solutions AS: POSITIVE TOPLINE SAFETY DATA FROM SIS-03 DOSE-ESCALATION PHASE

SoftOx Solutions

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release24.06.2026, 11.47

SoftOx Solutions AS: Minutes from the General Meeting

SoftOx Solutions
Regulatory press release24.06.2026, 08.00

SoftOx Solutions AS: First Quarter Report 2026

SoftOx Solutions
Regulatory press release09.06.2026, 09.48

SoftOx Solutions AS: Notice of General Assembly

SoftOx Solutions
Regulatory press release09.06.2026, 08.00

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release08.06.2026, 09.00

SoftOx Solutions AS: SIS-03 DOSE-ESCALATION PHASE COMPLETED AND INITIATION OF PROOF-OF-CONCEPT PHASE

SoftOx Solutions
Regulatory press release05.06.2026, 09.44

SoftOx Solutions AS: FIRST PARTICIPANT ENROLLED IN BIODEFENCE-FOCUSED SIS-02 PHASE 1 CLINICAL STUDY

SoftOx Solutions
Regulatory press release27.05.2026, 08.00

SoftOx Solutions AS: Annual Report 2025

SoftOx Solutions
Regulatory press release21.04.2026, 13.44

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release13.04.2026, 08.31

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release25.03.2026, 08.00

SoftOx Solutions AS: Fourth Quarter Report 2025

SoftOx Solutions
Regulatory press release24.03.2026, 21.36

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release11.03.2026, 10.00

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release03.03.2026, 08.24

SoftOx Solutions AS: First Subject Dosed in Combined Phase 2a Dose-Escalation and Proof-of-Concept Trial (SIS-03)

SoftOx Solutions
Regulatory press release25.02.2026, 08.00

SoftOx Defense Solutions AS: HPRA Approves SIS-02 Phase 1 Trial, Strengthening Dual-Use and Preparedness Strategy

SoftOx Solutions
Regulatory press release04.02.2026, 12.43

SoftOx Solutions AS: New Share Capital

SoftOx Solutions
Regulatory press release23.01.2026, 14.36

SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited

SoftOx Solutions
Regulatory press release29.12.2025, 09.33

SoftOx Solutions AS: Danish Medicines Agency Approves Phase 2a Trial for SoftOx Inhalation Solution

SoftOx Solutions